baber/WOPTO huggingface dataset:
Patent NZ-232002-A (NZ)
Title: Pharmaceutical composition comprising one phase containing medicament and another phase for delayed release of silicone oil
Inventor: MORTON OSWALD
IPC: A61K47/00
Filed: 1990-01-04
Abstract: PCT No. PCT/GB89/01545 Sec. 371 Date Aug. 28, 1991 Sec. 102(e) Date Aug. 28, 1991 PCT Filed Dec. 29, 1989 PCT Pub. No. WO90/07324 PCT Pub. Date Jul. 12, 1990.The invention provides a multiphase pharmaceutical composition for combatting an anorectal disease comprising at least one phase containing one or more medicaments for combatting said disease and at least one phase adapted for delayed release of a silicone oil whereby application of said composition at a region affected by said disease deposits said medicament or medicaments thereon and a layer of silicone oil is formed thereover, so protecting the medicaments from erosion by aqueous media.
Patent NZ-238391-A (NZ)
Title: Use of nalmefene(5-alpha)-17-(cyclopropylmethyl)-4,5-epoxy -6-methylenemorphinan-13,14-diol] in the preparation of medicaments for treating alcoholism
Inventor: SINCLAIR JOHN DAVID
IPC: A61K31/485
Filed: 1991-06-04
Abstract: A method for treating alcoholism. The alcohol-drinking response of alcoholics is extinguished by having them drink alcoholic beverages while nalmefene, an opiate antagonist, blocks the positive reinforcement effect of ethanol in the brain.
Patent NZ-240935-A (NZ)
Title: [hetero]aryl derivatives containing urea, carbamate or amide groupings; pharmaceutical compositions thereof
Inventor: FRANZMANN KARL WITOLD
IPC: A61P9/10
Filed: 1991-12-11
Abstract: The present invention is concerned with compounds of formula (I)    <IMAGE>  (I)  wherein Ar is a mono- or bicyclic aromatic group optionally containing one or two heteroatoms independently selected from nitrogen, oxygen and sulphur, said group being optionally substituted by one or more atoms or groups independently selected from halogen, nitro, amino, -NRR1 where R and R1 are independently selected from hydrogen, C1-8 alkyl and C1-8 alkanoyl, cyano, carboxyalkoxy, alkoxycarbonylalkoxy, C1-8 alkyl (including cycloalkyl and cycloalkylalkyl), C1-8 alkoxy (including cycloalkoxy and cycloalkylalkoxy), C1-8 thioalkyl, said alkyl, alkoxy and/or thioalkyl group(s) being optionally substituted by one or more halogen atoms, aryl, aryloxy, aralkyl and aralkyloxy, said aryl, aryloxy, aralkyl and/or aralkyloxy group(s) being optionally substituted by one or more atoms or groups independently selected from halogen, alkyl, alkoxy, alkanoyl, hydroxyalkyl, perfluoroalkyl, perfluoroalkoxy, carboxyalkoxy, alkoxycarbonylalkoxy, and C3-8 polyether groups containing from one to three oxygen atoms; D is -CH2-, -NH-, or -O-; E is -N< or -CH<; G is hydrogen, C1-12 straight, branched, or cyclic alkyl, or aralkyl, said aralkyl group being optionally substituted by one or more atoms or groups independently selected from halogen, amino, N-(C1-6 alkyl)amino, N,N-di(C1-6 alkyl)amino, C1-6 alkyl and C1-6 alkoxy, or a C3-8 polyether group containing one to three oxygen atoms; J is a bond or C1-6 straight or branched alkylene; n is an integer of from 0 to 10; R and R1 are as hereinbefore defined; and K is -CH2OH, -CHO, -CONHCH2CONH2, -CONH(C1-6 alkyl), -OC(C1-4 alkyl)2OCOheteroaryl, -CO2R2 where R2 is hydrogen, C1-8 alkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, or a C3-8 polyether group containing from one to three oxygen atoms, or -CONHAr' where Ar' is phenyl optionally substituted by one or more atoms or groups selected from fluorine, nitro, -NRR1 where R and R1 are as hereinbefore defined, C1-6 alkyl and C1-6 alkoxy, said alkyl and/or alkoxy group(s) being optionally substituted at the terminal carbon by -CO2R3 where R3 is C1-6 alkyl; and their physiologically functional derivatives, with processes for their preparation, with medicaments containing them and with their use as therapeutic agents, particularly in the prophylaxis and treatment of atherosclerosis.
Patent NZ-254555-A (NZ)
Title: Particulate dry laxative composition comprising a water-soluble cellulose ether, aspartame sweetener and maltodextrin
Inventor: PHADKE DEEPAK SHRIPAD
IPC: A61K9/14
Filed: 1993-07-09
Abstract: Water-dispersible sugar-free powdered, bulk laxative compositions containing cellulose ethers as the active agent are disclosed. These bulk laxative compositions form smooth, palatable dispersions in water which dispersions contain a therapeutically effective amount of the cellulose ether.
Patent NZ-272637-A (NZ)
Title: Xylanase derived from bacillus strain designated 720/1 (lmg-p-14798), its production and use
Inventor: DE BUYL ERIC
IPC: A23L35/00
Filed: 1995-07-25
Abstract: A xylanase (X) from a Bacillus strain that is active at pH 5-10 and between temps. of 50-80 degrees C, is new. Also claimed are: (i) a culture of Bacillus sp 720/1; (ii) a DNA encoding (X); (iii) an expression vector or chromosomal integration vector containing the DNA of (ii); (iv) a strain transformed with the vector of (iii); (v) an enzyme composition contg. (X) and at least one additive; (vi) a promoter sequence derived from the gene encoding B. pumilus PRL B12 xylanase; and (vii) a presequence derived from the gene encoding B. pumilus PRL B12 xylanase.
Patent NZ-273549-A (NZ)
Title: Movement detection; method and apparatus for detecting flying animals using microwave transmitted signal
Inventor: MUEHLEBACH JOHN FERDINAND
IPC: G01S13/536
Filed: 1994-09-14
Abstract: A method for detecting a flying animal whereby at least one transmitted signal is received, processed and filtered to provide a surveillance signal. An output signal is automatically controlled at a substantially constant level when the surveillance signal root mean squared value varies at a rate of change. The output signal is allowed to vary when the root mean squared value varies at a rate of change greater than said pre-defined threshold rate of change. Comparing the output signal against a predetermined value to provide an intruder detection signal indicative of the presence of a flying animal in the surveillance area.
Patent NZ-274915-A (NZ)
Title: N-(hetero)aryl methyl diazabicycloalkane derivatives
Inventor: HOWARD HARRY R
IPC: A61P25/26
Filed: 1994-11-14
Abstract: The present invention relates to diazabicyclic compounds and, specifically, to compounds of the formula wherein A, G, R1, R2, R3, R41 R5, R6, and R7 are as defined in the specification. The compounds of formula I are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent NZ-282169-A (NZ)
Title: Collapsible counter assembly with top panel having depending ribs
Inventor: CARR ARTHUR G
IPC: A47F9/00
Filed: 1995-02-15
Abstract: A collapsible counter assembly conceals and is supported by one or more members forming a support surface. The counter assembly includes a counter top structure including a top panel and one or more ribs defining one or more inwardly directed corners, the ribs extending downwardly from a bottom side of the top panel. One or more side portions extend around and are fastenable to the ribs to form a wall surrounding one or more members forming a support surface. Vertical side edges of the one or more side portions are attached together in one or more lap seams, each lap seam having an exterior edge disposed vertically below the one or more inwardly directed corners, thereby hiding the exterior edge.
Patent NZ-308661-A (NZ)
Title: Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
Inventor: NINKOV DUSAN
IPC: A61K36/53
Filed: 1996-05-24
Abstract: The invention relates to pharmaceutical compounds which are based on the anti-flammatory properties of etheric oils selected from the group consisting of Origanum vulgaris, Thymus vulgaris, Mentha piperita, Thymus serpilum, Saturea hortensis, Saturea montana, Saturea subricata, Carum corticum, Thymus zugis, Ocimum gratisimum, Moranda pungtata, Mosla japanoica and Salvia officinalis. Preferably the etheric oils, obtained at the distillation of Origanum vulgaris, Thymus vulgaris and/or Mentha piperita are used. Such pharmaceutical compounds, compared to synthetic sulfonamids, antibiotics and cortisones do not create biorecidives in the human body as well as in animal meat and milk and milk and do not contribute to the resistance of microorganism against pharmaceutical compositions in general. The composition according to the invention can be used in the treatment of colibacillosis, dermatomycosis, lice, perspiration and fungas on feet, dermatitis, acne and of veterinary diseases such as coccidiosis and mastitis.
Patent NZ-329305-A (NZ)
Title: Weather seal comprising a tapered cover having an elliptical or oval shaped flange
Inventor: HAYNES ANDREW LEO
IPC: E04B1/66
Filed: 1998-12-03
Abstract: A seal device 1, for use in sealing a join between a surface, e.g. a roof surface, and an elongate member 7, e.g. a pipe, projecting from the surface, comprises a tapered flexible cover having a first aperture 2 adapted to seal against the exterior of the elongate member, a second aperture 3 and a flange member 4 adapted to seal against the surface.  The flange member has a major axis and a minor axis and is substantially elliptical or oval in configuration whereby it is adapted to accommodate changes in the shape of the second aperture by the elongate member when projecting from the surface at an angle along the major axis.  The seal device further comprises means, e.g. corrugations 6a, 6b around the perimeter of the cover, for allowing adjustment of the position or orientation of the first aperture relative to the position or orientation of the second aperture.
Patent NZ-330117-A (NZ)
Title: 5-(thio or sulphonyl-phenyl) substituted isoquinoline derivatives and medicaments
Inventor: ISHIGURO SUSUMU
IPC: A61K31/495
Filed: 1998-08-07
Abstract: Novel isoquinoline derivatives represented by general formula (I) or pharmaceutically acceptable acid-addition salts thereof, prepared by aiming at providing novel compounds which have an inhibitory activity on nerve cell death of the apoptosis type, wherein Ar represents an optionally substituted aromatic ring; and n is 0, 1 or 2. Because of the inhibitory effect on cell death, these compounds are useful as preventives and remedies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's chorea and amyotrophic lateral sclerosis, ischemic cerebral diseases such as cerebral stroke, and peripheral nerve disorders observed in diabetes, etc. <CHEM>
Patent NZ-336882-A (NZ)
Title: System for culturing pathogenic microorganisms and viruses comprising two tangential flow filter devices
Inventor: KOPF HENRY B
IPC: B01D25/12
Filed: 1999-07-22
Abstract: Provided is a device for culturing pathogenic microorganisms and viruses to conserve laboratory space in a closed culture system. The first aspect of the device is a tangential flow filter system comprising: a)	a first tangential flow device comprising: i)	a first housing enclosing an interior volume; and ii)	one or more filter means separating the interior volume of the first housing into two or more chambers; b)	one or more substance addition means in fluid communication with one or more of the chambers of the first tangential flow device; c)	a second tangential flow device in fluid communication with one or more chambers of the first tangential flow device, the second tangential flow device comprising: i)	a second housing enclosing an interior volume; and ii)	one or more filter means separating the interior volume of the second housing into two or more chambers; and d)	a fluid exit means in fluid communication with the second tangential flow device. Also provided is a tangential flow filter system comprising a) to d) as described above, and wherein a first set of one or more chambers of the first tangential flow device are connected in loop fluid communication with a first set of one or more chambers of the second tangential flow device such that fluid exiting the first set of one or more chambers of the first tangential flow device flows into the first set of one or more chambers of the second tangential flow device, and fluid exiting the first set of one or more chambers of the second tangential flow device flows in to the first set of one or more chambers of the first tangential flow device.
Patent NZ-337678-A (NZ)
Title: Conveyor with pair of rollers at side to unload articles laterally
Inventor: WARKENTIN A JAMES
IPC: B65G47/248
Filed: 1998-02-09
Abstract: A conveyor of product units has mounting brackets (28) extending laterally from endless chains (14, 16). The mounting brackets rotatably mount two spools (34, 36) having axes (30, 32) parallel tothe conveying path. Pivotally mounted off-loading elements (48) can be articulated to lift product units positioned on the conveying system for off-loading laterally from the conveyor. A laterally articulated actuator is located below the principal conveyor. The actuator includes laterally slidable slats (not shown) which frictionally engage the overlying rollers (34, 36). Guides (not shown) move the slats laterally with the motion of the conveyor. With the lateral motion of the slats, the rollers are caused to rotate.
Patent NZ-502316-A (NZ)
Title: Header for milking units provided with a flow adjuster
Inventor: MARCO CATTANEO
IPC: A01J7/00
Filed: 2000-01-13
Abstract: Provided for is a header for milking units.  The header has:  (i) a bell (15) for collecting the milk (ii) a discharge unit (17) fixed to the bell (iii) a flow adjuster (1) attached to the inside of the header. The header unit is characterized in that the milked milk is aligned in such a manner that the individual milk flows are united into one circumferential, continuous and regular flow that discharges into the discharge duct (17).
Patent NZ-504541-A (NZ)
Title: A table assembly with extensible modesty screen such that as top of table is adjusted vertically screen maintains privacy to user
Inventor: FOOTITT IAN
IPC: E06B9/40
Filed: 1998-01-13
Abstract: Table top 42 is adjustable vertically and modesty screen 14 is correspondingly adjusted with the top of the screen moving with table top 42. Typically  screen has roller assembly 12 located under table top 42.
Patent NZ-509219-A (NZ)
Title: Treatment of wastewater with an inoculum of microorganisms prior to the treatment plant
Inventor: BELLAMY KENNETH MICHAEL
IPC: C02F9/00
Filed: 1999-06-29
Abstract: The treatment of wastewater and in particular to treatment of sewerage effluent is described.  A method of treating wastewater in a wastewater reticulation system is also described.  The method comprises inoculating the wastewater with an inoculum of selected microorganisms at a site prior to the treatment plant in the wastewater reticulation system or discharge site where there is no treatment plant in the wastewater reticulation system; and incubating the wastewater inoculated with the selected microorganisms to form a culture that reduces waste in the inoculated wastewater. The figures show an inoculation chamber (20) having a housing (21), an inlet (22), and an outlet (23).  The inoculation chamber (20) includes a support medium (31) that consists of four layers.  The base or first layer (24) consists of crushed zeolite.  A second layer (25) consists of porous, clay or concrete perforated bricks.  These bricks may also be stacked on top of each other to increase the depth of the layer (25).  The third layer (26) consists of crushed zeolite and provides a flat surface for the fourth layer (27).  The fourth layer (27) consists of biologically activated ceramic (28) mounted on polyethylene rods (29).  The polyethylene rods (29) are connected together by an elongate shaft (30), which serves as a backbone holding the rods (29) relative to each other.  The shaft (30) is made of stainless steel.  The flow of the wastewater effluent entering the inoculation chamber (20) from the inlet (22) becomes turbulent because of the position of the biologically activated ceramic (28) lying transversely across the direction of flow.  The turbulence mixes the wastewater effluent, aerates the wastewater effluent, and inoculates the wastewater effluent with microorganisms from the biologically activated ceramic (28) as it passes over and through the support medium.  The inoculation chamber also includes a spray nozzle (33) connected to a dosing line (34), which in turn is connected to an inoculum reservoir.  The spray nozzle (33) sprays the effluent with inoculum of selected microorganisms.
Patent NZ-511171-A (NZ)
Title: Methods for large-scale production of recombinant AAV vectors
Inventor: BYRNE BARRY J
IPC: C12N15/869
Filed: 1999-09-22
Abstract: Disclosed are HSV-1 amplicons that supply all necessary helper functions required for rAAV packaging and methods for their use. These HSV-1 amplicons have been shown to be capable of rescuing and replicating all forms of rAAV genomes including rAAV genomes introduced into cells by infection of rAAV virions, rAAV genomes transfected into cells on plasmids or proviral rAAV genomes integrated into cellular chromosomal DNA. Also provided are methods for preparing high-titer rAAV vector compositions suitable for gene therapy and the delivery of exogenous polynucleotides to selected host cells.
Patent NZ-511855-A (NZ)
Title: Formulation containing nucleotide analog (adefovir dipivoxil or AD)
Inventor: DAHL TERRENCE C
IPC: A61K47/10
Filed: 1999-12-14
Abstract: A composition comprises the nucleotide analog 9-[2-[[bis[(pivaloyloxy)methyl]phosphono] methoxy] thyl] adenine (adefovir dipivoxil or "AD") and an alkaline excipient with or without L-carnitine-L-tartrate. The usual AD structure is given in the diagram.
Patent NZ-517758-A (NZ)
Title: Pyrazolopyrimidines useful as therapeutic agents
Inventor: HIRST GAVIN C
IPC: A61P25/00
Filed: 2000-09-15
Abstract: Disclosed herein are compounds of formula (I), their pharmaceutically acceptable salts and/or prodrugs thereof that are suitable for use as inhibitors protein kinase such as a protein serine/threonine kinase or a protein tyrosine kinase, where G, R2 and R3 are defined as defined in the specification.
Patent NZ-518070-A (NZ)
Title: Improvements relating to cooling of molds
Inventor: JAMES MALCOLM BARRY
IPC: B29C45/73
Filed: 2000-09-25
Abstract: An arrangement to assist in heat transfer through a mold for applications such as injection molding of plastics material including at least one closed chamber within the mold, the chamber being only partially filled with liquid and a remainder of the chamber being filled with substantially only vapour of the liquid within the chamber, at least a portion of the chamber being positioned to transmit heat from a targeted location of the mold into liquid within the chamber, and condensing means adapted by reason of heat exchange to effect condensation of vapour within the chamber, the mold being arranged in that the liquid such as water is arranged to be held in the chamber in such a way that the liquid will be distributed to reach or be held at different heights within the chamber. This is achieved in one case by the addition of a foaming agent in the liquid. In another case by having a flock attached to the inner surface of the chamber. In a further example there are separate tiers of reservoirs holding the liquid above a base level of the liquid.
Patent NZ-521328-A (NZ)
Title: A pipe connector
Inventor: WORMALL SHANE JOHN
IPC: E03F5/02
Filed: 2001-03-09
Abstract: A pipe connector (10) including a joining portion (12) having a port (14) for connection of a first pipe thereto, the joining portion also having a wall for connection of a second pipe thereto, the second pipe being able to be connected to the wall by boring a hole through the wall and bonding the second pipe thereto, the wall having a shape such that the pipe may be bonded to the wall at a plurality of angles with respect to the port, whereby, in use, the pipe connector can connect the first pipe to the second pipe at a plurality of angles with respect to each other.
Patent NZ-521818-A (NZ)
Title: Composition comprising cyclopropene encapsulated in a molecular encapsulation agent (e.g. cyclodextrin) and a carbon dioxide generating additive (e.g. acid in combination with a carbonate or bicarbonate)
Inventor: KOSTANSEK EDWARD CHARLES
IPC: A01N27/00
Filed: 2002-10-07
Abstract: A composition for the enhanced release of a cyclopropene from a molecular encapsulation agent within the cyclopropene is encapsulated comprising: a) a cyclopropene of the formula disclosed; where R is hydrogen or a substituted or unsubstituted alkyl, alkynyl, alkenyl, cycloalkyl, cycloalkylalkyl, phenyl or napthyl group. The substituents are independently halogen, alkoxy, or substituted or unsubstituted phenoxy; b) a molecular encapsulation agent within which the cyclopropene is encapsulated; and c) one or more carbon dioxide generating additives. A method for the production of a cyclopropene of the formula disclosed is also given.
Patent NZ-524540-A (NZ)
Title: Discrimination between GnRH-I and GnRH-II
Inventor: MELOEN ROBERT HANS
IPC: A61K39/00
Filed: 2001-09-11
Abstract: A peptide that comprises a modified GnRH decapeptide sequence wherein at least one of the amino acids is replaced by alanine; a vaccine comprising the peptide; a method for immunocastrating a pig comprising vaccinating the pig with the vaccine; isolated or synthetic antibodies against GnRH-II; and the use of the peptide in the preparation of a medicament for the treatment of prostate cancer.
Patent NZ-525465-A (NZ)
Title: Slot drain
Inventor: LITTLE COLIN GEORGE
IPC: E03F5/04
Filed: 2003-04-23
Abstract: A slot drain (100) comprises a throat portion (104) having two walls (110) and a separator (112) arranged to separate the walls. To provide an easy way of retaining the separator in position, the separator has lateral projections (122, 124) which pass through holes (128) in the walls and are bent over to retain the walls against the separator.
Patent NZ-530606-A (NZ)
Title: Parking meter enforcement system
Inventor: REINHARDT SYDNEY JAMES
IPC: G07B15/02
Filed: 2002-07-05
Abstract: A parking meter system adapted for issuing a parking citation against a vehicle (136) that has been parked during a first time period in a parking space (108) associated with a parking meter (104) is disclosed. The system comprises a central system (102), a portable terminal enforcement terminal (116) and means for establishing parking citation data for the vehicle comprising: a) means for establishing a communications link between the portable enforcement terminal and the central system and downloading contextual data for the parking meter from the central system to the terminal; and b) means for establishing a communications link between the portable enforcement terminal and the parking meter and downloading parking status data for the vehicle from the parking meter to the terminal. c) means for automatically ascertaining an operational status for the parking meter during a first time period; and d) means for producing the parking citation, if according to the parking citation data and the operational status, the vehicle is in violation. The citation includes the parking citation data and the operational status. The contextual data comprises at least one of mete location information associated with the particular meters and information about parking rules applicable to particular meters. The parking citation data comprises at least the contextual data or the parking status data.
Patent NZ-531586-A (NZ)
Title: Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
Inventor: SALVATI PATRICIA
IPC: A61K31/16
Filed: 2002-08-09
Abstract: A pharmaceutical composition comprising gabapentinor pregabalin or a pharmaceutically acceptable derivative thereof and an alpha-aminoamide selected from the group consisting of (S)-(+)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide, (R)-(-)-2-[4-benzyloxybenzylamino]-3-phenyl-N-methylpropanamide, and (S)-(+)-2-[4-(3-fluorobenzyloxy)-benzylamino]-N-methyl-propanamide, is disclosed. The composition is useful in the treatment of pain.